315 related articles for article (PubMed ID: 16445657)
21. Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia.
Gatta LB; Berenzi A; Balzarini P; Dessy E; Angiero F; Alessandri G; Gambino A; Grigolato P; Benetti A
Int J Gynecol Pathol; 2011 Nov; 30(6):597-604. PubMed ID: 21979598
[TBL] [Abstract][Full Text] [Related]
22. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
[TBL] [Abstract][Full Text] [Related]
23. p16
Vital D; Holzmann D; Huber GF; Soyka MB; Moch H; Zimmermann DR; Ikenberg K
Head Neck; 2017 Jul; 39(7):1392-1398. PubMed ID: 28371015
[TBL] [Abstract][Full Text] [Related]
24. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
[TBL] [Abstract][Full Text] [Related]
25. Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis.
Ferrándiz-Pulido C; Masferrer E; de Torres I; Lloveras B; Hernandez-Losa J; Mojal S; Salvador C; Morote J; Ramon y Cajal S; Pujol RM; Garcia-Patos V; Toll A
J Am Acad Dermatol; 2013 Jan; 68(1):73-82. PubMed ID: 22863066
[TBL] [Abstract][Full Text] [Related]
26. Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.
Carestiato FN; Amaro-Filho SM; Moreira MAM; Cavalcanti SMB
Mem Inst Oswaldo Cruz; 2018 Dec; 114():e180456. PubMed ID: 30569945
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of the diagnostic and prognostic significance of p16(INK4a) /p21(WAF1/Cip1) immunostaining in squamous intraepithelial lesions of the uterine cervix using liquid-based cytology specimens.
Ishida K; Araki A; Kobayashi M; Taniyama K; Nabika T; Nagasaki M
Diagn Cytopathol; 2014 Feb; 42(2):125-33. PubMed ID: 23754829
[TBL] [Abstract][Full Text] [Related]
28. Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias.
Venturoli S; Ambretti S; Mirasoli M; Santini D; Zerbini M; Roda A; Musiani M
Int J Gynecol Pathol; 2008 Oct; 27(4):575-81. PubMed ID: 18753961
[TBL] [Abstract][Full Text] [Related]
29. p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells.
Piaton E; Casalegno JS; Advenier AS; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A; Mekki Y
Cancer Cytopathol; 2014 Oct; 122(10):760-9. PubMed ID: 25069600
[TBL] [Abstract][Full Text] [Related]
30. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
31. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
[TBL] [Abstract][Full Text] [Related]
32. Combining routine morphology, p16(INK4a) immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: a tissue microarray study using classifier performance analyses.
Chaux A; Cubilla AL; Haffner MC; Lecksell KL; Sharma R; Burnett AL; Netto GJ
Urol Oncol; 2014 Feb; 32(2):171-7. PubMed ID: 23499169
[TBL] [Abstract][Full Text] [Related]
33. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
[TBL] [Abstract][Full Text] [Related]
34. HPV infection and p16
Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection.
Steinestel J; Cronauer MV; Müller J; Al Ghazal A; Skowronek P; Arndt A; Kraft K; Schrader M; Schrader AJ; Steinestel K
PLoS One; 2013; 8(5):e65189. PubMed ID: 23724131
[TBL] [Abstract][Full Text] [Related]
36. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
37. Performance of HPV E4 and p16
Damgaard RK; Jenkins D; de Koning MN; Quint WG; Stoler MH; Doorbar J; Kahlert J; Gravitt PE; Steiniche T; Petersen LK; Hammer A
BMJ Open; 2022 Jul; 12(7):e059593. PubMed ID: 35793925
[TBL] [Abstract][Full Text] [Related]
38. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer.
Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Costa S; Benedetto A; Casolati EA; Favalli C; Paba P; Di Bonito P; Mariani L; Syrjänen S; Bonifacio D; Accardi L; Zanconati F; Syrjänen K;
Am J Clin Pathol; 2005 Jul; 124(1):113-21. PubMed ID: 15923164
[TBL] [Abstract][Full Text] [Related]
39. The prevalence of human papillomavirus in oral premalignant lesions and squamous cell carcinoma in comparison to cervical lesions used as a positive control.
Ishibashi M; Kishino M; Sato S; Morii E; Ogawa Y; Aozasa K; Kogo M; Toyosawa S
Int J Clin Oncol; 2011 Dec; 16(6):646-53. PubMed ID: 21528380
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia.
Sano T; Masuda N; Oyama T; Nakajima T
Pathol Int; 2002; 52(5-6):375-83. PubMed ID: 12100520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
